Expanded allogeneic adipose-derived mesenchymal stromal cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Expanded allogeneic adipose-derived mesenchymal stromal cells, covering 2023-08-25 to 2023-08-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis [Phase 1, Phase 2]